Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-12-17

Clinical Trial Update: Towards Reducing Resistance and Hematological Toxicity of Linezolid

View source ↗

Summary

This completed clinical trial investigates strategies to reduce linezolid resistance and hematologic toxicity in infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linezolid (Linezolid)

Snippet

Sponsor: University of Pittsburgh | Conditions: Infection, Adverse Effects | Status: COMPLETED